Back to search
Hearing Aids
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hearing Aids trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hearing Aids trials you may qualify forRegeneron is conducting a study of an investigational new drug called DB-OTO. DB-OTO is a gene therapy that is being developed to treat children who have hearin…
Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time. This st…
Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time. This st…
This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheime…
Every year, approximately 100,000 Veterans seek help at VA Audiology clinics for hearing and communication difficulties only to learn that they have normal hear…
Since 2000, at least 250,000 U.S. Service members have experienced a blast-related mild traumatic brain injury. A retrospective analysis of over 100,000 post-9/…
This study aims to examine the knowledge levels and attitudes of students enrolled in departments other than Audiology within the Faculty of Health Sciences reg…
Hearing loss is one of the most common chronic disabilities in the older adult population and affects their quality of life. Hearing aid use can improve one's q…
The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investi…